{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:00:34Z","timestamp":1787313634660,"version":"build-2736575974"},"reference-count":57,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T00:00:00Z","timestamp":1681689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>In patients with pulmonary hypertension (PH), increased pulmonary vascular resistance (PVR) may lead to increased right ventricular afterload and cardiac remodelling, potentially providing the substrate for ventricular arrhythmias. Studies dealing with long term monitoring of patients with PH are rare. The present study evaluated the incidence and the types of arrhythmias retrospectively recorded by Holter ECG in patients with newly detected PH during a long-term Holter ECG follow-up. Moreover, their impact on patient survival was evaluated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and methods<\/jats:title>\n                    <jats:p>\n                      Medical records were screened for demographic data, aetiology of PH, incidence of coronary heart disease, level of brain natriuretic peptide (BNP), results from Holter ECG monitoring, 6-minute walk test distance, echocardiographic data and hemodynamic data derived from right heart catheterization. Two subgroups were analyzed: 1. patients (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200965) with PH (group 1\u2009+\u20094) and derivation of at least 1 Holter ECG within 12 months from initial detection of PH and 2. patients (all PH etiologies,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200959) with 3 follow-up Holter ECGs. The frequency and complexity of premature ventricular contractions (PVC) was classified into \u201clower\u201d and \u201chigher\u201d (=non sustained ventricular tachycardia, nsVT) burden.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Holter ECG revealed sinus rhythm (SR) in most of the patients (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200960). Incidence of atrial fibrillation (AFib) was low (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20094). Patients with premature atrial contractions (PAC) tend to have a shorter period of survival (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.098), PVC were not correlated with significant survival differences. During follow-up PAC and PVC were common in all PH groups. Holter ECG revealed non sustained ventricular tachycardia in 19\/59 patients [(32.2%);\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20096 during first Holter-ECG,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200913 during second\/third Holter-ECG]. In all patients suffering from nsVT during follow-up previous Holter ECG revealed multiform\/repetitive PVC. PVC burden was not linked to differences in systolic pulmonary arterial pressure, right atrial pressure, brain natriuretic peptide and results of six-minute walk test.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Patients with PAC tend to have a shortened survival. None of the evaluated parameters (BNP, TAPSE, sPAP) was correlated with the development of arrhythmias. Patients with multiform\/repetitive PVC seem to be at risk for ventricular arrhythmias.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcvm.2023.1084051","type":"journal-article","created":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T01:47:25Z","timestamp":1681696045000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Incidence and prognostic significance of malignant arrhythmias during (repetitive) Holter electrocardiograms in patients with pulmonary hypertension"],"prefix":"10.3389","volume":"10","author":[{"given":"Dirk","family":"Bandorski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Heibel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhard","family":"H\u00f6ltgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harilaos","family":"Bogossian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein Ardeschir","family":"Ghofrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Zarse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henning","family":"Gall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,4,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","article-title":"2022 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"43","author":"Humbert","year":"2022","journal-title":"Eur Heart J"},{"key":"B2","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1093\/eurheartj\/ehv317","article-title":"ESC_ERS guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"46","author":"Gali\u00e8","year":"2015","journal-title":"Eur Respir J"},{"key":"B3","doi-asserted-by":"publisher","first-page":"D42","DOI":"10.1016\/j.jacc.2013.10.032","article-title":"Definitions and diagnosis of pulmonary hypertension","volume":"62","author":"Hoeper","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1801913","DOI":"10.1183\/13993003.01913-2018","article-title":"Haemodynamic definitions and updated clinical classification of pulmonary hypertension","volume":"53","author":"Simonneau","year":"2019","journal-title":"Eur Respir J"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1016\/S0140-6736(03)13167-4","article-title":"Primary pulmonary hypertension","volume":"361","author":"Runo","year":"2003","journal-title":"Lancet"},{"key":"B6","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1161\/CIRCEP.111.967265","article-title":"Spontaneous ventricular fibrillation in right ventricular failure secondary to chronic pulmonary hypertension","volume":"5","author":"Umar","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"H2833","DOI":"10.1152\/ajpheart.1997.272.6.H2833","article-title":"Stage-dependent changes in membrane currents in rats with monocrotaline-induced right ventricular hypertrophy","volume":"272","author":"Lee","year":"1997","journal-title":"Am J Physiol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1016\/j.ijcard.2012.06.024","article-title":"Atrial flutter and fibrillation in patients with pulmonary hypertension","volume":"167","author":"Olsson","year":"2013","journal-title":"Int J Cardiol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e33902","DOI":"10.1371\/journal.pone.0033902","article-title":"Clinical impact of atrial fibrillation in patients with pulmonary hypertension","volume":"7","author":"Rottlaender","year":"2012","journal-title":"PLoS ONE"},{"key":"B10","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ijcard.2010.09.065","article-title":"Clinical implications of supraventricular arrhythmias in patients with severe pulmonary arterial hypertension","volume":"146","author":"Ruiz-Cano","year":"2011","journal-title":"Int J Cardiol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ahj.2006.09.008","article-title":"Incidence and clinical relevance of supraventricular tachyarrhythmias in pulmonary hypertension","volume":"153","author":"Tongers","year":"2007","journal-title":"Am Heart J"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1016\/j.amjcard.2014.07.079","article-title":"Frequency of supraventricular arrhythmias in patients with idiopathic pulmonary arterial hypertension","volume":"114","author":"Wen","year":"2014","journal-title":"Am J Cardiol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"617565","DOI":"10.1155\/2014\/617565","article-title":"Electrophysiological studies in patients with pulmonary hypertension: a retrospective investigation","volume":"2014","author":"Bandorski","year":"2014","journal-title":"Biomed Res Int"},{"key":"B14","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00399-015-0364-8","article-title":"Ventricular tachycardias in patients with pulmonary hypertension: an underestimated prevalence? A prospective clinical study","volume":"26","author":"Bandorski","year":"2015","journal-title":"Herzschrittmacherther Elektrophysiol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"465","DOI":"10.5603\/CJ.a2016.0044","article-title":"Evaluation of the prognostic value of electrocardiography parameters and heart rhythm in patients with pulmonary hypertension","volume":"23","author":"Bandorski","year":"2016","journal-title":"Cardiol J"},{"key":"B16","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1093\/eurheartj\/ehz467","article-title":"2019 ESC guidelines for the management of patients with supraventricular tachycardiaThe task force for the management of patients with supraventricular tachycardia of the European society of cardiology (ESC)","volume":"41","author":"Brugada","year":"2020","journal-title":"Eur Heart J"},{"key":"B17","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","article-title":"2022 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"43","author":"Zeppenfeld","year":"2022","journal-title":"Eur Heart J"},{"key":"B18","doi-asserted-by":"publisher","first-page":"3427","DOI":"10.1093\/eurheartj\/ehab364","article-title":"2021 ESC guidelines on cardiac pacing and cardiac resynchronization therapy","volume":"42","author":"Glikson","year":"2021","journal-title":"Eur Heart J"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.1093\/eurheartj\/ehq249","article-title":"ESC Guidelines for the management of grown-up congenital heart disease (new version 2010)","volume":"31","author":"Baumgartner","year":"2010","journal-title":"Eur Heart J"},{"key":"B20","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1161\/01.CIR.44.1.130","article-title":"Approaches to sudden death from coronary heart disease","volume":"44","author":"Lown","year":"1971","journal-title":"Circulation"},{"key":"B21","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1136\/hrt.45.6.717","article-title":"Analysis of prognostic significance of ventricular arrhythmias after myocardial infarction. Shortcomings of lown grading system","volume":"45","author":"Bigger","year":"1981","journal-title":"Br Heart J"},{"key":"B22","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1093\/europace\/eur342","article-title":"Ventricular automaticity as a predictor of sudden death in ischaemic heart disease","volume":"14","author":"Bastiaenen","year":"2012","journal-title":"Europace"},{"key":"B23","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1055\/s-2008-1068485","article-title":"Ventricular arrhythmias in cor pulmonale. The effect of oxygen treatment","volume":"111","author":"Machraoui","year":"1986","journal-title":"Dtsch Med Wochenschr"},{"key":"B24","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1093\/eurheartj\/ehl199","article-title":"ACC\/AHA\/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death\u2013executive summary: a report of the American college of cardiology\/American heart association task force and the European society of cardiology committee for practice guidelines (writing committee to develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death) developed in collaboration with the European heart rhythm association and the heart rhythm society","volume":"27","author":"Zipes","year":"2006","journal-title":"Eur Heart J"},{"key":"B25","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1164\/ajrccm.166.1.at1102","article-title":"ATS Statement: guidelines for the six-minute walk test","volume":"166","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.echo.2008.11.029","article-title":"Echocardiographic assessment of valve stenosis: eAE\/ASE recommendations for clinical practice","volume":"22","author":"Baumgartner","year":"2009","journal-title":"J Am Soc Echocardiogr"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American society of echocardiography and the European association of cardiovascular imaging","volume":"28","author":"Lang","year":"2015","journal-title":"J Am Soc Echocardiogr"},{"key":"B28","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.echo.2010.05.010","article-title":"Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American society of echocardiography endorsed by the European association of echocardiography, a registered branch of the European society of cardiology, and the Canadian society of echocardiography","volume":"23","author":"Rudski","year":"2010","journal-title":"J Am Soc Echocardiogr"},{"key":"B29","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/S0894-7317(03)00335-3","article-title":"Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography","volume":"16","author":"Zoghbi","year":"2003","journal-title":"J Am Soc Echocardiogr"},{"key":"B30","doi-asserted-by":"publisher","first-page":"43","DOI":"10.15420\/aer.2018.3.2","article-title":"Atrial arrhythmias in pulmonary hypertension: pathogenesis, prognosis and management","volume":"7","author":"Wanamaker","year":"2018","journal-title":"Arrhythm Electrophysiol Rev"},{"key":"B31","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00399-020-00668-w","article-title":"Tachycardia and pulmonary arterial hypertension","volume":"31","author":"Bandorski","year":"2020","journal-title":"Herzschrittmacherther Elektrophysiol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.ijcard.2021.03.047","article-title":"Assessment of cardiac arrhythmias using long-term continuous monitoring in patients with pulmonary hypertension","volume":"334","author":"Andersen","year":"2021","journal-title":"Int J Cardiol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"e0245752","DOI":"10.1371\/journal.pone.0245752","article-title":"The prevalence and clinical outcome of supraventricular tachycardia in different etiologies of pulmonary hypertension","volume":"16","author":"Fingrova","year":"2021","journal-title":"PLoS ONE"},{"key":"B34","doi-asserted-by":"publisher","first-page":"586","DOI":"10.5603\/KP.a2017.0257","article-title":"Advanced and traditional electrocardiographic risk factors in pulmonary arterial hypertension: the significance of ventricular late potentials","volume":"76","author":"Uznanska-Loch","year":"2018","journal-title":"Kardiol Pol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1002\/clc.23803","article-title":"The spectrum and prevalence of arrhythmia in different clinical pulmonary hypertension groups in Chinese population","volume":"45","author":"Xue","year":"2022","journal-title":"Clin Cardiol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1016\/j.amjcard.2015.09.039","article-title":"Supraventricular arrhythmias in patients with pulmonary arterial hypertension","volume":"116","author":"Cannillo","year":"2015","journal-title":"Am J Cardiol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s10840-014-9928-5","article-title":"Incidence, predictors, and clinical course of atrial tachyarrhythmias in patients with pulmonary hypertension","volume":"41","author":"Kanmanthareddy","year":"2014","journal-title":"J Interv Card Electrophysiol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.hlc.2015.10.008","article-title":"The management of supraventricular tachyarrhythmias in patients with pulmonary arterial hypertension","volume":"25","author":"Malaczynska-Rajpold","year":"2016","journal-title":"Heart Lung Circ"},{"key":"B39","doi-asserted-by":"publisher","first-page":"2045894018790316","DOI":"10.1177\/2045894018790316","article-title":"Atrial arrhythmias are associated with increased mortality in pulmonary arterial hypertension","volume":"8","author":"Smith","year":"2018","journal-title":"Pulm Circ"},{"key":"B40","doi-asserted-by":"publisher","first-page":"e002192","DOI":"10.1161\/JAHA.115.002192","article-title":"Prognostic significance of premature atrial complexes burden in prediction of long-term outcome","volume":"4","author":"Lin","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"B41","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1093\/europace\/euy276","article-title":"Frequent premature atrial contractions are associated with atrial fibrillation, brain ischaemia, and mortality: a systematic review and meta-analysis","volume":"21","author":"Himmelreich","year":"2019","journal-title":"Europace"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1327265","DOI":"10.1155\/2016\/1327265","article-title":"Prognostic relevance of nonsustained ventricular tachycardia in patients with pulmonary hypertension","volume":"2016","author":"Bandorski","year":"2016","journal-title":"Biomed Res Int"},{"key":"B43","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/5584_2016_18","article-title":"Heart rate variability and arrhythmic burden in pulmonary hypertension","volume":"934","author":"Witte","year":"2016","journal-title":"Adv Exp Med Biol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.hrtlng.2014.05.010","article-title":"Heart rate variability parameters and ventricular arrhythmia correlate with pulmonary arterial pressure in adult patients with idiopathic pulmonary arterial hypertension","volume":"43","author":"Yi","year":"2014","journal-title":"Heart Lung"},{"key":"B45","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.jjcc.2016.12.013","article-title":"Chronic obstructive pulmonary disease and atrial fibrillation: an unknown relationship","volume":"69","author":"Goudis","year":"2017","journal-title":"J Cardiol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1159\/000442447","article-title":"Atrial and ventricular arrhythmia-associated factors in stable patients with chronic obstructive pulmonary disease","volume":"91","author":"Kusunoki","year":"2016","journal-title":"Respiration"},{"key":"B47","first-page":"19","article-title":"Clinical implications and prognostic significance of the study on the circadian variation of heart rate variability in patients with severe pulmonary hypertension","volume":"142","author":"Rosas-Peralta","year":"2006","journal-title":"Gac Med Mex"},{"key":"B48","doi-asserted-by":"publisher","first-page":"H2230","DOI":"10.1152\/ajpheart.01226.2010","article-title":"Arrhythmogenic substrate in hearts of rats with monocrotaline-induced pulmonary hypertension and right ventricular hypertrophy","volume":"300","author":"Benoist","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1165\/rcmb.2012-0089OC","article-title":"Right ventricular electrical remodeling and arrhythmogenic substrate in rat pulmonary hypertension","volume":"49","author":"Tanaka","year":"2013","journal-title":"Am J Respir Cell Mol Biol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.hrthm.2021.09.021","article-title":"Right predominant electrical remodeling in a pure model of pulmonary hypertension promotes reentrant arrhythmias","volume":"19","author":"Strauss","year":"2022","journal-title":"Heart Rhythm"},{"key":"B51","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.yjmcc.2018.11.017","article-title":"Intra-tracheal gene delivery of aerosolized SERCA2a to the lung suppresses ventricular arrhythmias in a model of pulmonary arterial hypertension","volume":"127","author":"Strauss","year":"2019","journal-title":"J Mol Cell Cardiol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1161\/CIRCULATIONAHA.113.001873","article-title":"Right ventricular diastolic impairment in patients with pulmonary arterial hypertension","volume":"128","author":"Rain","year":"2013","journal-title":"Circulation"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1161\/CIRCULATIONAHA.115.020696","article-title":"Bone morphogenetic protein receptor type 2 mutation in pulmonary arterial hypertension: a view on the right ventricle","volume":"133","author":"van der Bruggen","year":"2016","journal-title":"Circulation"},{"key":"B54","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1111\/j.1540-8167.2011.02255.x","article-title":"Atrial electrical and structural remodeling associated with longstanding pulmonary hypertension and right ventricular hypertrophy in humans","volume":"23","author":"Medi","year":"2012","journal-title":"J Cardiovasc Electrophysiol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3346\/jkms.2012.27.2.215","article-title":"Radiofrequency catheter ablation of hemodynamically unstable ventricular tachycardia associated with systemic sclerosis","volume":"27","author":"Chung","year":"2012","journal-title":"J Korean Med Sci"},{"key":"B56","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1016\/S0735-1097(01)01625-4","article-title":"Electroanatomic mapping of arrhythmogenic right ventricular dysplasia","volume":"38","author":"Boulos","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s11897-020-00479-7","article-title":"Cardiac magnetic resonance imaging in pulmonary arterial hypertension: ready for clinical practice and guidelines?","volume":"17","author":"Kjellstrom","year":"2020","journal-title":"Curr Heart Fail Rep"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2023.1084051\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T01:47:28Z","timestamp":1681696048000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2023.1084051\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,17]]},"references-count":57,"alternative-id":["10.3389\/fcvm.2023.1084051"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2023.1084051","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,17]]},"article-number":"1084051"}}